Title: Progress of research on the clearance of indoxyl sulfate
Abstract:Indoxyl sulfate (IS) is a uremic toxin that is a small molecule solute, as many as 90% of which bind to the plasma proteins. IS derives from the breakdown of tryptophan by gut microbes. Normal renal f...Indoxyl sulfate (IS) is a uremic toxin that is a small molecule solute, as many as 90% of which bind to the plasma proteins. IS derives from the breakdown of tryptophan by gut microbes. Normal renal function can lead to IS excretion through the tubular secretion, while impaired renal function can result in accumulation of IS in the body. So plasma IS levels are elevated in patients with chronic kidney disease (CKD). IS has nephrotoxicity, and can cause renal interstitial fibrosis and glomerulosclerosis, accelerating the progression of CKD. IS also has cardiovascular toxicity, leading to myocardial fibrosis and left ventricular hypertrophy, etc. Cardiovascular disease has been widely recognized as the leading cause of death in CKD patients. Studies have found that IS can increase the risk of all-cause death and cardiovascular death in patients with end-stage renal disease (ESRD). Therefore, it is very important to reduce plasma IS level by means of dialysis or non-dialysis method. This article summarized the research results on IS clearance by domestic and foreign scholars in recent years.
Key words:
Indoxyl sulfate; Chronic kidney disease; Cardiovascular disease; Dialysis; ClearanceRead More
Publication Year: 2017
Publication Date: 2017-12-28
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot